Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Surgery Partners, Inc. has received an average rating of “Moderate Buy” from analysts, with three hold ratings and six buy ratings among the nine firms covering the stock.
• The company's stock price has a one-year low of $18.87 and a high of $33.90, currently trading around $21.87.
• In its latest earnings report, Surgery Partners reported $0.17 EPS and revenue of $826.20 million, exceeding analyst expectations for both metrics.

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have earned an average rating of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $33.00.

A number of equities research analysts have recently commented on SGRY shares. Barclays lowered their target price on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Bank of America assumed coverage on Surgery Partners in a report on Monday, July 28th. They issued a "buy" rating and a $28.00 price objective for the company.

Surgery Partners Trading Down 1.1%

NASDAQ SGRY opened at $21.87 on Monday. The stock has a market capitalization of $2.80 billion, a price-to-earnings ratio of -15.29 and a beta of 1.76. Surgery Partners has a one year low of $18.87 and a one year high of $33.90. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. The business's fifty day moving average is $22.45 and its 200-day moving average is $22.54.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.01. The company had revenue of $826.20 million for the quarter, compared to analysts' expectations of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The business's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.21 EPS. Equities research analysts predict that Surgery Partners will post 0.67 EPS for the current year.

Insider Activity

In related news, Director Teresa Deluca sold 20,018 shares of Surgery Partners stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total value of $455,209.32. Following the completion of the sale, the director owned 45,173 shares of the company's stock, valued at approximately $1,027,234.02. This trade represents a 30.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Harrison R. Bane sold 9,339 shares of Surgery Partners stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $22.48, for a total value of $209,940.72. Following the completion of the sale, the insider directly owned 117,181 shares of the company's stock, valued at approximately $2,634,228.88. This trade represents a 7.38% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.70% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in SGRY. AlphaQuest LLC grew its holdings in Surgery Partners by 112.0% during the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock valued at $25,000 after buying an additional 559 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in Surgery Partners by 86.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after buying an additional 542 shares in the last quarter. Summit Securities Group LLC purchased a new position in Surgery Partners during the 1st quarter valued at about $31,000. DekaBank Deutsche Girozentrale purchased a new position in Surgery Partners during the 1st quarter valued at about $65,000. Finally, State of Wyoming grew its holdings in Surgery Partners by 94.4% during the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after buying an additional 1,943 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.